Contrasting effects of filamin A and B proteins in modulating filovirus entry

Author:

Shepley-McTaggart Ariel,Liang Jingjing,Ding Yang,Djurkovic Marija A.,Kriachun Valeriia,Shtanko Olena,Sunyer Oriol,Harty Ronald N.ORCID

Abstract

Ebola (EBOV) and Marburg viruses (MARV) cause severe hemorrhagic fever associated with high mortality rates in humans. A better understanding of filovirus-host interactions that regulate the EBOV and MARV lifecycles can provide biological and mechanistic insight critical for therapeutic development. EBOV glycoprotein (eGP) and MARV glycoprotein (mGP) mediate entry into host cells primarily by actin-dependent macropinocytosis. Here, we identified actin-binding cytoskeletal crosslinking proteins filamin A (FLNa) and B (FLNb) as important regulators of both EBOV and MARV entry. We found that entry of pseudotype psVSV-RFP-eGP, infectious recombinant rVSV-eGP-mCherry, and live authentic EBOV and MARV was inhibited in filamin A knockdown (FLNaKD) cells, but was surprisingly enhanced in filamin B knockdown (FLNbKD) cells. Mechanistically, our findings suggest that differential regulation of macropinocytosis by FLNa and FLNb likely contributes to their specific effects on EBOV and MARV entry. This study is the first to identify the filamin family of proteins as regulators of EBOV and MARV entry. These findings may provide insight into the development of new countermeasures to prevent EBOV and MARV infections.

Funder

National Institute of Allergy and Infectious Diseases

National Eye Institute

Texas Biomedical Research Institute

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference56 articles.

1. World Health Organization: Ebola virus disease Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON398 [

2. Ebola virus disease;D Malvy;The Lancet,2019

3. Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention;E Nicastri;Infect Dis Clin North Am,2019

4. Exotic emerging viral diseases: progress and challenges;TW Geisbert;Nat Med,2004

5. CDC. Bioterrorism Agents/Diseases. https://emergencycdcgov/agent/agentlist-categoryasp.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3